Medicare Demos Should Not Be Used To Boost Provider Payments – MedPAC
Medicare demonstration projects should be used to test innovations in delivery and quality of care and not to increase payments to providers, the Medicare Payment Advisory Commission (MedPAC) agreed at a Dec. 8 meeting
You may also be interested in...
An HHS Office of Inspector General "1special advisory bulletin" on manufacturer-sponsored patient assistance programs for Medicare Part D beneficiaries will force companies to restructure these programs
The Centers for Medicare & Medicaid Services is revising its cancer "quality of care" demonstration project to evaluate oncologists' adherence to evidence-based practice guidelines
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011